Response to FiercePharma Article

CLIENT: Pierian Biosciences DATE: February 17, 2017 PROJECT: PR – Blog post – Response to FiercePharma article Author: Robert Henry A recent FiercePharma article on the top 15 cancer drugs for 2022 predicts they will total nearly $90 billion in sales. That’s a...

Pierian Biosciences Names Mark S. Gelder, MD as Chief Medical Officer

Oncology Professor to Guide Clinical Studies Pierian Biosciences, the premier developer of life science technologies providing treatment directing data to aid physicians in selecting the most appropriate therapy for their patients with cancer, has named Mark S....